Menu Search
Equities

PW Medtech Group Ltd

1358:HKG.HS

PW Medtech Group Ltd

Actions
  • Price (HKD)1.00
  • Today's Change0.00 / 0.00%
  • Shares traded331.00k
  • 1 Year change+106.19%
  • Beta--
Data delayed at least 15 minutes, as of May 17 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

PW Medtech Group Limited is an investment holding company principally engaged in the development, manufacturing and sales of medical devices. The Company operates through three business segments. The Infusion Set Business segment is engaged in the manufacturing and sales of infusion sets. The Orthopedic Implant Business segment is engaged in the manufacturing and sales of orthopedic implant products, including product category of trauma, spine and joints. The Regenerative Medical Biomaterial Business segment is engaged in the manufacturing and sales of regenerative medical biomaterial products.

  • Revenue in HKD (TTM)730.31m
  • Net income in HKD165.72m
  • Incorporated2011
  • Employees1.24k
  • Location
    PW Medtech Group LtdLevel 54Hopewell Centre, 183 Queen's Road EastBEIJING 00000ChinaCHN
  • Phone+86 1 084783617
  • Fax+86 1 084783657
  • Websitehttps://www.pwmedtech.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.